[Advances on human amniotic epithelial cells and its clinical application potential]

Area of Science:

• Stem Cell Biology
• Regenerative Medicine
• Tissue Engineering

Background:

• Human amniotic epithelial cells (hAECs) are derived from the embryonic epiblast, distinguishing them from other placental stem cells.
• hAECs exhibit both embryonic stem cell-like multi-differentiation and adult stem cell-like immunomodulatory properties.
• Unique advantages include easy isolation, abundant supply, non-tumorigenicity, and ethical acceptability.

Purpose of the Study:

• To provide a comprehensive review of hAEC biological characteristics.
• To summarize the current research status of hAECs.
• To discuss the clinical application prospects of hAEC-based cell therapy.

Main Methods:

• Literature review of studies on hAEC biology and therapeutic applications.
• Analysis of research findings on hAEC differentiation and immunomodulatory functions.
• Evaluation of clinical trial data and preclinical studies.

Main Results:

• hAECs demonstrate significant potential in repairing and remodeling damaged tissues and organs.
• Multiple molecular mechanisms underlie the therapeutic efficacy of hAECs.
• Extensive research over two decades supports their therapeutic viability.

Conclusions:

• hAECs represent a promising cell source for regenerative medicine.
• Their unique properties facilitate diverse therapeutic applications.
• Further clinical translation of hAEC-based therapies is warranted.